Efficacy and safety of FTY720 in patients who receive a kidney transplant.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Fingolimod (Primary) ; Ciclosporin; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis; Novartis Pharmaceuticals
- 01 Nov 2011 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 29 Nov 2005 New trial record.